trending Market Intelligence /marketintelligence/en/news-insights/trending/M89onIGps1psdzta6VTr9w2 content esgSubNav
In This List

Johnson & Johnson exits insulin pump market, closes operations

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Johnson & Johnson exits insulin pump market, closes operations

Johnson & Johnson is exiting the insulin pump market.

The company said it would discontinue manufacturing and selling the Animas, Vibe and OneTouch Ping insulin pumps, offering patients the option to transfer to Medtronic plc products instead.

While the company will continue to provide customer service, training and warranty support, it has already stopped selling the products in the U.S. and Canada and is working on a decision and timing to exit other countries.

Earlier this year, Johnson & Johnson said it was looking to sell its consumer-oriented diabetes devices business after steady declines in the segment since 2011.

That announcement came a year after the company said it was restructuring its medical device businesses as part of a plan to save up to $1 billion per year through 2018.